MedPath

Retrospective Observational Cohort Study of SYMBOL CUP DM 1

Completed
Conditions
Primary Total Hip Arthroplasty
Interventions
Device: THA with SYMBOL CUP DM HA
Registration Number
NCT04209374
Lead Sponsor
Dedienne Sante S.A.S.
Brief Summary

This is a single-center retrospective observational cohort study of consecutively operated patients who underwent primary total hip arthroplasty with a SYMBOL CUP DM HA hemispherical dual mobility acetabular implant. The purpose of this study is to estimate the safety and efficacy of that implant at two-year follow-up.

Detailed Description

Description according to PICOS framework:

Patients:

- Adult men and women requiring a primary total hip arthroplasty

Intervention:

- Primary THA with SYMBOL CUP DM HA hemispherical dual mobility acetabular implant.

Comparator: None

Outcomes:

* Safety 1: Implant survival over 2-year follow-up.

* Safety 2: All adverse events, with focus on implant dislocation, infections, revision surgery

* Efficacy 1: Harris Hip Score (HHS) at baseline and 1-year follow-up.

* Efficacy 2: Modified HHS consisting of pain + functional subscores at baseline, 1-year and 2-year follow-ups.

* Efficacy 2: Devane score at baseline, 1-year and 2-year follow-ups.

* Efficacy 3: Charnley classification at baseline, 1-year and 2-year follow-ups.

Study design:

* single-center retrospective observational cohort study of consecutively operated patients who underwent primary total hip arthroplasty 2 years prior to study start.

* Prospective 2-year follow-up letter and phone questionnaire.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • All patients with total hip implant using hemispheric dual-mobility SYMBOL CUP DM HA
  • Operation performed by the primary investigator
  • Delay between index operation and March 1 2018 has reached 2 years
Exclusion Criteria
  • patient refusal to participate in the study
  • minors (age < 18 years)
  • patients under guardianship

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
HMB-DMR-HATHA with SYMBOL CUP DM HAPrimary total hip arthroplasty with hemispherical dual-mobility acetabular cup
Primary Outcome Measures
NameTimeMethod
Implant survival: Ratio of the number of participants alive with the complete index hip prosthesis in position at 2-year follow-up, over their initial numberprosthesis in position at 2-year follow-up, over their initial number.2 years as of index operation

This is the ratio of the number of participants who are alive with the complete index hip prosthesis in position at a given follow-up time (numerator) over the initial number of those participants from the date they received the index hip prosthesis (denominator). The cumulative ratio is recalculated at each event using the Kaplan-Meier method from the date of each participant index operation through the date of each participant's death or prosthetic removal surgery or loss-to-follow-up or last assessment alive with the hip prosthesis in place. The longest duration between the index operation and the final assessment is 2 years.

Secondary Outcome Measures
NameTimeMethod
Number of patients with one or several post-operative adverse events and count of each Serious adverse event and aggregate count of adverse events2 years as of index operation

All serious post-operative adverse events are taken into account including implant dislocation, infections, revision surgery

Harris Hip Score (HHS) at baseline and 1-year follow-up1 year as of index operation

The score is measured at each assessment in each patient. The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments

The modified Harris Hip Score (modified HHS) at baseline, 1-year and 2-year follow-up2 years as of index operation

The modified Harris Hip Score (modified HHS) is the sum of pain subscore and functional subscore of the Harris Hip Score. The score is measured at each assessment in each patient. The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments

Devane classification at baseline, 1-year and 2-year follow-up.2 years as of index operation

The class is measured at each assessment in each patient. The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments

Charnley classification at baseline, 1-year and 2-year follow-up.2 years as of index operation

The class is measured at each assessment in each patient. The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments

Trial Locations

Locations (1)

Lyon Ortho Clinic - Clinique de la Sauvegarde

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath